BioPorto A/S (CPH:BIOPOR)
0.9320
-0.0080 (-0.85%)
Apr 15, 2026, 4:59 PM CET
BioPorto Employees
BioPorto had 46 employees as of December 31, 2025. The number of employees decreased by 2 or -4.17% compared to the previous year.
Employees
46
Change
-2
Growth
-4.17%
Revenue / Employee
875.80K DKK
Profits / Employee
-1.79M DKK
Market Cap
465.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | -2 | -4.17% |
| Sep 30, 2025 | 48 | 12 | 33.33% |
| Jun 30, 2025 | 48 | 21 | 77.78% |
| Mar 31, 2025 | 48 | 21 | 77.78% |
| Dec 31, 2024 | 48 | 19 | 65.52% |
| Sep 30, 2024 | 36 | 3 | 9.09% |
| Mar 31, 2024 | 27 | -12 | -30.77% |
| Dec 31, 2023 | 29 | -3 | -9.38% |
| Sep 30, 2023 | 33 | 2 | 6.45% |
| Jun 30, 2023 | 36 | 5 | 16.13% |
| Mar 31, 2023 | 39 | 10 | 34.48% |
| Dec 31, 2022 | 32 | 3 | 10.34% |
| Sep 30, 2022 | 31 | 3 | 10.71% |
| Dec 31, 2021 | 29 | 1 | 3.57% |
| Sep 30, 2021 | 28 | 1 | 3.70% |
| Jun 30, 2021 | 29 | 3 | 11.54% |
| Mar 31, 2021 | 29 | 3 | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Coloplast | 16,983 |
| Genmab | 2,973 |
| ALK-Abelló | 2,613 |
| Gubra | 300 |
| ChemoMetec | 172 |
| Scandinavian Medical Solutions | 29 |
| ViroGates | 7 |
BioPorto News
- 15 days ago - BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis - GlobeNewsWire
- 20 days ago - Notice convening the Annual General Meeting in BioPorto A/S - GlobeNewsWire
- 20 days ago - BioPorto announces the Annual Report for 2025 - GlobeNewsWire
- 27 days ago - BioPorto Successfully Completes Preliminary Analysis of U.S. Adult NGAL Cutoff Study; Pre-Submission expected by End of Q1 2026 - GlobeNewsWire
- 2 months ago - BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update - GlobeNewsWire
- 5 months ago - BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes - GlobeNewsWire
- 5 months ago - Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S - GlobeNewsWire
- 5 months ago - BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement - GlobeNewsWire